Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2010 2
2011 2
2012 2
2013 1
2014 1
2016 6
2017 3
2018 4
2019 4
2020 3
2021 4
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.
Bisogno G, De Salvo GL, Bergeron C, Gallego Melcón S, Merks JH, Kelsey A, Martelli H, Minard-Colin V, Orbach D, Glosli H, Chisholm J, Casanova M, Zanetti I, Devalck C, Ben-Arush M, Mudry P, Ferman S, Jenney M, Ferrari A; European paediatric Soft tissue sarcoma Study Group. Bisogno G, et al. Among authors: mudry p. Lancet Oncol. 2019 Nov;20(11):1566-1575. doi: 10.1016/S1470-2045(19)30617-5. Epub 2019 Sep 24. Lancet Oncol. 2019. PMID: 31562043 Clinical Trial.
Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study.
Bisogno G, Minard-Colin V, Zanetti I, Ferrari A, Gallego S, Dávila Fajardo R, Mandeville H, Kelsey A, Alaggio R, Orbach D, Terwisscha van Scheltinga S, Guillén Burrieza G, Ben-Arush M, Glosli H, Mudry P, Ferman S, Devalck C, Defachelles AS, Merks JHM, Jenney M. Bisogno G, et al. Among authors: mudry p. J Clin Oncol. 2023 May 1;41(13):2342-2349. doi: 10.1200/JCO.22.02093. Epub 2023 Feb 27. J Clin Oncol. 2023. PMID: 36848614 Clinical Trial.
Future paradigms for precision oncology.
Klement GL, Arkun K, Valik D, Roffidal T, Hashemi A, Klement C, Carmassi P, Rietman E, Slaby O, Mazanek P, Mudry P, Kovacs G, Kiss C, Norga K, Konstantinov D, André N, Slavc I, van Den Berg H, Kolenova A, Kren L, Tuma J, Skotakova J, Sterba J. Klement GL, et al. Among authors: mudry p. Oncotarget. 2016 Jul 19;7(29):46813-46831. doi: 10.18632/oncotarget.9488. Oncotarget. 2016. PMID: 27223079 Free PMC article. Review.
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity.
Sterba M, Pokorna P, Faberova R, Pinkova B, Skotakova J, Seehofnerova A, Blatny J, Janigova L, Koskova O, Palova H, Mahdal M, Pazourek L, Jabandziev P, Slaby O, Mudry P, Sterba J. Sterba M, et al. Among authors: mudry p. Sci Rep. 2023 Jun 28;13(1):10499. doi: 10.1038/s41598-023-37468-4. Sci Rep. 2023. PMID: 37380669 Free PMC article.
Transcription factor c-Myb: novel prognostic factor in osteosarcoma.
Říhová K, Dúcka M, Zambo IS, Vymětalová L, Šrámek M, Trčka F, Verner J, Drápela S, Fedr R, Suchánková T, Pavlatovská B, Ondroušková E, Kubelková I, Zapletalová D, Tuček Š, Múdry P, Krákorová DA, Knopfová L, Šmarda J, Souček K, Borsig L, Beneš P. Říhová K, et al. Among authors: mudry p. Clin Exp Metastasis. 2022 Apr;39(2):375-390. doi: 10.1007/s10585-021-10145-4. Epub 2022 Jan 7. Clin Exp Metastasis. 2022. PMID: 34994868
Childhood cancer epidemiology in the Czech Republic (1994-2016).
Krejci D, Zapletalova M, Svobodova I, Bajciova V, Mudry P, Smelhaus V, Sterba J, Stary J, Capocaccia R, Dusek L. Krejci D, et al. Among authors: mudry p. Cancer Epidemiol. 2020 Dec;69:101848. doi: 10.1016/j.canep.2020.101848. Epub 2020 Nov 19. Cancer Epidemiol. 2020. PMID: 33223489
Clinicopathological correlation of tumor-associated macrophages in Ewing sarcoma.
Handl M, Hermanova M, Hotarkova S, Jarkovsky J, Mudry P, Shatokhina T, Vesela M, Sterba J, Zambo I. Handl M, et al. Among authors: mudry p. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Mar;162(1):54-60. doi: 10.5507/bp.2017.049. Epub 2017 Nov 21. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018. PMID: 29170560 Free article.
Risk factors for tumors or leukemia development in the first two years of life.
Wiedermannova H, Mudry P, Pavlicek J, Tomaskova H, Hladikova A, Palova H, Vesela P, Slaby O, Sterba J. Wiedermannova H, et al. Among authors: mudry p. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023 Sep;167(3):246-253. doi: 10.5507/bp.2022.004. Epub 2022 Feb 11. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023. PMID: 35147139 Free article.
Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing.
Pokorna P, Lakka Klement G, Vasikova A, Kanderova V, Jezova M, Noskova K, Mudry P, Kyr M, Merta T, Bajciova V, Krenova Z, Palova H, Valik D, Zdrazilova Dubska L, Slaby O, Sterba J. Pokorna P, et al. Among authors: mudry p. JCO Precis Oncol. 2022 Jun;6:e2100525. doi: 10.1200/PO.21.00525. JCO Precis Oncol. 2022. PMID: 35700412 Free PMC article. No abstract available.
37 results